National Medical Care Co.

As of June 30, 2026, National Medical Care Co. carries a market capitalization of 4.63B, placing it among publicly traded companies globally. Its enterprise value stands at 5.19B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

National Medical Care Co.'s next confirmed earnings release is scheduled for November 3, 2026.

As of June 30, 2026, National Medical Care Co. has 44.69M shares outstanding.

As of June 30, 2026, National Medical Care Co. trades at a trailing price-to-earnings ratio of 15.45. The price-to-sales ratio is 2.79, and the price-to-book ratio stands at 2.49.

As of June 30, 2026, National Medical Care Co. trades at an EV/EBITDA multiple of 11.31 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 3.12 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 15.16 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 5.19B versus a market cap of 4.63B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, National Medical Care Co. maintains a current ratio of 5.02, meaning it holds 5.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 42.86, indicating elevated leverage, while an interest coverage ratio of 16.02 demonstrates strong ability to service its debt obligations.

Over the twelve months ended June 30, 2026, National Medical Care Co. posted a return on equity (ROE) of 16.79, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 13.52 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 10.76, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 13.52, useful for judging operating efficiency across full business cycles. Inventory turnover of 14.87 indicates how many times National Medical Care Co. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, National Medical Care Co. recorded 28.11M in income tax expense. That works out to an effective tax rate of 8.58, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 327.70M, leaving 299.59M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, National Medical Care Co.'s stock has declined approximately 46.73% over the past 52 weeks. The 50-day moving average sits at 114.15, while the 200-day moving average is 122.51.

Over the twelve months ended June 30, 2026, National Medical Care Co. generated 1.66B in revenue and converted that into 299.59M in net income, yielding earnings per share of 6.70. EBITDA reached 458.29M, while operating income came in at 341.66M.

As of June 30, 2026, National Medical Care Co. holds 242.77M in cash and equivalents against 798.39M in total debt, resulting in a net debt position of 248.16M. Total book value stands at 1.86B, with working capital of 1.18B providing operational flexibility.

National Medical Care Co. produced -46.56M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -239.30M in capital expenditures, free cash flow totaled -285.87M - equivalent to -6.40 per share.

Over the twelve months ended June 30, 2026, National Medical Care Co. posted a gross margin of 35.52, reflecting its pricing power and cost economics. The operating margin of 20.56 and net profit margin of 18.03 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, National Medical Care Co. paid dividends of - - per share. The dividend payout ratio of - - indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield is negative at -6.17: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -1.11, meaning National Medical Care Co. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of June 30, 2026, National Medical Care Co. has an Altman Z-Score of 4.53, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.